A new report by Funders Concerned About AIDS (FCAA) revealed that global private funding for HIV totalled US$ 618 million, an 8% increase (US$46 million) from 2013.
The 2014 increase was driven by significant increases from the top two funders, the Bill & Melinda Gates Foundation and Gilead Sciences, Inc. This influence is reflective of the ongoing overall concentration of HIV/AIDS philanthropic funding among the top donors: the top 20 funders accounted for 81% of all funding in 2014. Overall, funding has been holding relatively steady around the $600-650 million mark for the past eight years.
Other key findings include:
• The Bill & Melinda Gates Foundation, Gilead Sciences, Inc., M.A.C AIDS Fund, Wellcome Trust and the Ford Foundation ranked as the top five philanthropic HIV funders in 2014. Most funding ($262 million) went to grants with a global (non-country-specific) reach. The increase in funding from 2013 to 2014 was mostly directed to the U.S. domestic epidemic and almost entirely attributable to increased contributions to the U.S. from one funder (Gilead Sciences,Inc,). This brings private philanthropic funding for HIV/AIDS in the U.S. to a new high of $139 million in 2014, making it the top recipient country of private funding. The top region outside of the U.S. to receive private philanthropic funding was East & Southern Africa ($114 million).
• Half of all country-level funding in 2014 went to high-income countries ($177 million), while over a third ($125 million) went to middle-income countries.
• The overall top reported target population was funding for a general population ($261 million), mostly for research grants, but also for prevention and advocacy grants benefiting a general population. The next top five target populations in 2014 were people living with HIV where no sub-population was indicated ($133 million), women & girls ($69 million), youth ($53 million), economically disadvantaged/homeless people ($47 million), and pregnant women/mothers and babies ($41 million).
(information taken from FCAA)